These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. 1,25-Dihydroxyvitamin D attenuates diabetic cardiac autophagy and damage by vitamin D receptor-mediated suppression of FoxO1 translocation. Guo X, Lin H, Liu J, Wang D, Li D, Jiang C, Tang Y, Wang J, Zhang T, Li Y, Yao P. J Nutr Biochem; 2020 Jun; 80():108380. PubMed ID: 32299030 [Abstract] [Full Text] [Related]
8. FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity. Gopal K, Al Batran R, Altamimi TR, Greenwell AA, Saed CT, Tabatabaei Dakhili SA, Dimaano MTE, Zhang Y, Eaton F, Sutendra G, Ussher JR. Cell Rep; 2021 Apr 06; 35(1):108935. PubMed ID: 33826891 [Abstract] [Full Text] [Related]
9. Exogenous hydrogen sulfide attenuates the development of diabetic cardiomyopathy via the FoxO1 pathway. Ye P, Gu Y, Zhu YR, Chao YL, Kong XQ, Luo J, Ren XM, Zuo GF, Zhang DM, Chen SL. J Cell Physiol; 2018 Dec 06; 233(12):9786-9798. PubMed ID: 30078216 [Abstract] [Full Text] [Related]
11. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis. Qi B, He L, Zhao Y, Zhang L, He Y, Li J, Li C, Zhang B, Huang Q, Xing J, Li F, Li Y, Ji L. Diabetologia; 2020 May 06; 63(5):1072-1087. PubMed ID: 32072193 [Abstract] [Full Text] [Related]
13. Effects of Sodium-Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice. Croteau D, Luptak I, Chambers JM, Hobai I, Panagia M, Pimentel DR, Siwik DA, Qin F, Colucci WS. J Am Heart Assoc; 2021 Jul 06; 10(13):e019995. PubMed ID: 34169737 [Abstract] [Full Text] [Related]
14. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression. Qi Y, Zhu Q, Zhang K, Thomas C, Wu Y, Kumar R, Baker KM, Xu Z, Chen S, Guo S. Circ Heart Fail; 2015 Jan 06; 8(1):198-208. PubMed ID: 25477432 [Abstract] [Full Text] [Related]
15. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes. Ramírez E, Klett-Mingo M, Ares-Carrasco S, Picatoste B, Ferrarini A, Rupérez FJ, Caro-Vadillo A, Barbas C, Egido J, Tuñón J, Lorenzo Ó. Cardiovasc Diabetol; 2013 Nov 21; 12():172. PubMed ID: 24261558 [Abstract] [Full Text] [Related]
16. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate. Piao L, Sidhu VK, Fang YH, Ryan JJ, Parikh KS, Hong Z, Toth PT, Morrow E, Kutty S, Lopaschuk GD, Archer SL. J Mol Med (Berl); 2013 Mar 21; 91(3):333-46. PubMed ID: 23247844 [Abstract] [Full Text] [Related]
20. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Yu M, Liu Y, Zhang B, Shi Y, Cui L, Zhao X. Cardiovasc Pathol; 2015 Mar 21; 24(6):375-81. PubMed ID: 26164195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]